The bill amends various sections of the Idaho Code concerning the practice of pharmacy, focusing on the regulation of pharmacists and the Board of Pharmacy. Key changes include the repeal of Section 54-1703, which previously stated the purpose of the law, and the introduction of new definitions in Section 54-1704, such as "collaborative pharmacy practice" and "hazardous drug." The bill also revises existing definitions related to licensure and the duties of the Board of Pharmacy, while establishing new sections that outline licensing fees, renewal requirements for pharmacist licenses, and standards for drug outlets. Additionally, it repeals outdated sections and introduces new provisions for minimum facility standards, reporting requirements, and labeling standards for prescription drugs, all aimed at enhancing the regulatory framework for pharmacy practice in Idaho.

Moreover, the bill introduces significant amendments regarding the prescribing and dispensing of medications, allowing pharmacists to independently prescribe under specific conditions and establishing new standards for prescription drug labeling. It also sets forth detailed requirements for compounding practices and clarifies that licensed drug outlets are exempt from obtaining separate controlled substance registrations. The bill enhances the prescription tracking program, mandating that drug outlets report data on controlled substances by the end of the business day, which will aid in identifying illegal activities. Overall, the bill seeks to modernize Idaho's pharmacy laws, ensuring they align with current standards and practices while prioritizing public health and safety.

Statutes affected:
Bill Text: 54-1702, 54-1703, 54-1704, 54-1705, 54-1706, 54-1714, 54-1718, 54-1719, 54-1720, 54-1721, 54-1722, 54-1723, 54-1723A, 54-1723B, 54-1725, 54-1726, 54-1728, 54-1729, 54-1729A, 54-1730, 54-1731, 54-1732, 54-1733, 54-1734, 54-1736, 54-1738, 54-1739, 54-1760, 54-1771, 37-2716, 37-2730A, 54-5705